|
Credit investor Silver Rock Capital Partners has raised more than $4bn of investable capital for the latest vintage of its Tactical Allocation strategy.
The post Silver Rock Capital, born from Michael Milken's family office, raises $4bn for credit investing appeared first on AltAssets Private Equity News.
|
|
Astorg has agreed a roughly $1bn buyout of Thermo Fisher Scientific's microbiology business. The arm, which provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing, generated $645m in revenue last year. Thermo Fisher expects the deal to close in the second half of 2026. Astorg said the market was […]
The post Deal Roundup: Astorg agrees $1bn buyout of Thermo Fisher microbiology unit, O2 Investment backs Steffl Drilling & Pump appeared first on AltAssets Private Equity News.
|
|